Clinical Trial Update: Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on the Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for detecting chemotherapy-induced apoptosis across phase 2 and phase 3 stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Ovarian Cancer
• Soft Tissue Sarcoma

Snippet

Sponsor: Pierian Biosciences | Conditions: Breast Neoplasms, Lung Neoplasms | Phase 2, Phase 3 | Status: COMPLETED